Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Alpine Immune Sciences In...

    NASDAQ: ALPN · Real-Time Price · USD
    64.97
    0.01 (0.02%)
    At close: May 17, 2024, 10:00 PM

    Alpine Immune Sciences Statistics

    Share Statistics

    Alpine Immune Sciences has 68.6M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 68.6M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 47.88M

    Failed to Deliver (FTD) Shares

    n/a
    		 7

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -29.61 and the forward PE ratio is null. Alpine Immune Sciences's PEG ratio is 0.47.

    PE Ratio

    n/a
    		 -29.61

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 16.19

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 2.91

    P/FCF Ratio

    n/a
    		 -11.99

    PEG Ratio

    n/a
    		 0.47
    Financial Ratio History

    Enterprise Valuation

    Alpine Immune Sciences has an Enterprise Value (EV) of 919M.

    EV / Sales

    n/a
    		 15.61

    EV / EBITDA

    n/a
    		 -21.04

    EV / EBIT

    n/a
    		 -11.63

    EV / FCF

    n/a
    		 -11.56

    Financial Position

    The company has a current ratio of 7.86, with a Debt / Equity ratio of 0.03.

    Current Ratio

    n/a
    		 7.86

    Quick Ratio

    n/a
    		 7.87

    Debt / Equity

    n/a
    		 0.03

    Debt / EBITDA

    n/a
    		 -0.23

    Debt / FCF

    n/a
    		 -0.12

    Interest Coverage

    n/a
    		 -451.53

    Financial Efficiency

    Return on Equity is -9.81% and Return on Invested Capital is -13.14%.

    Return on Equity

    n/a
    		 -9.81%

    Return on Assets

    n/a
    		 -8.47%

    Return on Invested Capital

    n/a
    		 -13.14%

    Revenue Per Employee

    n/a
    		 $414,619.72

    Profits Per Employee

    n/a
    		 $-226,647.88

    Employee Count

    n/a
    		 142

    Asset Turnover

    n/a
    		 0.15

    Inventory Turnover

    n/a
    		 -484.46

    Taxes

    Income Tax

    n/a
    		 103K

    Effective Tax Rate

    n/a
    		 -0.32%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 0.97, so Alpine Immune Sciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.97

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 53.07

    200-Day Moving Average

    n/a
    		 26.53

    Relative Strength Index (RSI)

    n/a
    		 83.31

    Average Volume (20 Days)

    n/a
    		 2,371,991

    Income Statement

    In the last 12 months, Alpine Immune Sciences had revenue of 58.88M and earned -32.18M in profits. Earnings per share was -0.64.

    Revenue

    n/a
    		 58.88M

    Gross Profit

    n/a
    		 -22.03M

    Operating Income

    n/a
    		 -44.25M

    Net Income

    n/a
    		 -32.18M

    EBITDA

    n/a
    		 -43.67M

    EBIT

    n/a
    		 -31.98M

    Earnings Per Share (EPS)

    n/a
    		 -0.64
    Full Income Statement

    Balance Sheet

    The company has 43.92M in cash and 9.91M in debt, giving a net cash position of 34.01M.

    Cash & Cash Equivalents

    n/a
    		 43.92M

    Total Debt

    n/a
    		 9.91M

    Net Cash

    n/a
    		 34.01M

    Retained Earnings

    n/a
    		 -256.14M

    Total Assets

    n/a
    		 373.65M

    Working Capital

    n/a
    		 276.01M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -79.01M and capital expenditures -487K, giving a free cash flow of -79.5M.

    Operating Cash Flow

    n/a
    		 -79.01M

    Capital Expenditures

    n/a
    		 -487K

    Free Cash Flow

    n/a
    		 -79.5M

    FCF Per Share

    n/a
    		 -1.59
    Full Cash Flow Statement

    Margins

    Gross margin is -37.41%, with operating and profit margins of -75.16% and -54.66%.

    Gross Margin

    n/a
    		 -37.41%

    Operating Margin

    n/a
    		 -75.16%

    Pretax Margin

    n/a
    		 -54.49%

    Profit Margin

    n/a
    		 -54.66%

    EBITDA Margin

    n/a
    		 -74.18%

    EBIT Margin

    n/a
    		 -75.16%

    FCF Margin

    n/a
    		 -135.03%

    Dividends & Yields

    ALPN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -3.38%

    FCF Yield

    n/a
    		 -8.34%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ALPN.

    Price Target

    n/a
    		 $65

    Price Target Difference

    n/a
    		 0%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 9.75

    Graham Upside

    n/a
    		 -84.99%

    Stock Splits

    The last stock split was on Jul 25, 2017. It was a backward split with a ratio of 1:4.

    Last Split Date

    n/a
    		 Jul 25, 2017

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:4

    Scores

    Altman Z-Score

    n/a
    		 64.92

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist